Amalgamated Bank’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
RI
VCM
ICM
Amalgamated Bank's FLGT Position: Q1 2026 in Review
Amalgamated Bank sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 650 shares — an estimated $17K sold.
Amalgamated Bank first reported a position in FLGT in Q2 2021 and held it in 19 quarters. The position peaked at $945K in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.
- Amalgamated Bank reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 650 Fulgent Genetics shares in Q1 2026, an estimated $17K.
- Amalgamated Bank first reported a position in Fulgent Genetics in Q2 2021 and held it in 19 quarters.
- Amalgamated Bank's Fulgent Genetics position peaked at $945K in Q4 2021.
- 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.